[india-drug] Spanish version of the WHO Model Formulary 2004

["Dr Hans V. Hogerzeil" <hogerzeilh@who.ch>]

Spanish version of the WHO Model Formulary 2004


Dear e-druggers,
We are happy to announce that electronic files (MS Word and PDF format)
of the Spanish version of the WHO Model Formulary 2004 are now
available at:
http://mednet3.who.int/eml/wmf/Spanish/index.htm
Since the 1st edition published in 2002, the WHO Model Formulary has
become an important source of independent information on essential
medicines for pharmaceutical policy-makers and prescribers worldwide. 
For each medicine on the WHO Model List of Essential Medicines, the
Model Formulary provides information on use, dosage, adverse effects,
contraindications and warnings, supplemented by guidance on selecting
the right medicine for a range of conditions.
The electronic files available at the link above can be used as a
starting point for developing national or local formularies.  National
or institutional committees can use the text of the Model Formulary for
their own needs by adapting it, or by adding or deleting entries to
align the formulary to their own list of essential medicines.

Dr Hans V. Hogerzeil
Director a.i.
Essential Drugs and Medicines Policy
WHO Geneva


________________________________________________________________________
Yahoo! India Careers: Over 50,000 jobs online
Go to: http://yahoo.naukri.com/

Access Essential Drugs Monitor #32 at http://www.who.int/medicines/mon/mon32.shtml

The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.

To send a message to india-drug, write to: india-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@healthnet.org